These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 28774563)
21. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years. Block SL; Toback SL; Yi T; Ambrose CS Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885 [TBL] [Abstract][Full Text] [Related]
23. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. Wang Z; Tobler S; Roayaei J; Eick A JAMA; 2009 Mar; 301(9):945-53. PubMed ID: 19255113 [TBL] [Abstract][Full Text] [Related]
24. Safety of live attenuated influenza vaccine in atopic children with egg allergy. Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M; J Allergy Clin Immunol; 2015 Aug; 136(2):376-81. PubMed ID: 25684279 [TBL] [Abstract][Full Text] [Related]
25. The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults. Ambrose CS; Wu X Vaccine; 2013 Jan; 31(6):857-60. PubMed ID: 23261050 [TBL] [Abstract][Full Text] [Related]
26. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age. Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS Vaccine; 2012 Apr; 30(19):2989-98. PubMed ID: 22386746 [TBL] [Abstract][Full Text] [Related]
28. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age. Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS Vaccine; 2012 Apr; 30(20):3053-60. PubMed ID: 22425787 [TBL] [Abstract][Full Text] [Related]
29. Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)? Merckx J; McCormack D; Quach C Vaccine; 2016 Feb; 34(6):750-6. PubMed ID: 26752064 [TBL] [Abstract][Full Text] [Related]
30. Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Talbot TR; Crocker DD; Peters J; Doersam JK; Ikizler MR; Sannella E; Wright PE; Edwards KM Infect Control Hosp Epidemiol; 2005 May; 26(5):494-500. PubMed ID: 15954490 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children. Heikkinen T; Block SL; Toback SL; Wu X; Ambrose CS Pediatr Infect Dis J; 2013 Jun; 32(6):669-74. PubMed ID: 23271441 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Coelingh K; Olajide IR; MacDonald P; Yogev R Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891 [TBL] [Abstract][Full Text] [Related]
35. Adverse events associated with intranasal influenza vaccine in the United States. Vasu N; Ghaffari G; Craig ET; Craig TJ Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371 [TBL] [Abstract][Full Text] [Related]
36. Vaccines for preventing influenza in people with cystic fibrosis. Tan A; Bhalla P; Smyth R Cochrane Database Syst Rev; 2000; (2):CD001753. PubMed ID: 10796814 [TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers. Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566 [TBL] [Abstract][Full Text] [Related]
39. The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine. Panapasa JA; Cox RJ; Mohn KG; Aqrawi LA; Brokstad KA Hum Vaccin Immunother; 2015; 11(7):1663-72. PubMed ID: 26148331 [TBL] [Abstract][Full Text] [Related]
40. Parents' preferences for seasonal influenza vaccine for their children in Japan. Shono A; Kondo M Vaccine; 2014 Sep; 32(39):5071-6. PubMed ID: 25063570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]